Virginie Shandley
About Virginie Shandley
Virginie Shandley is the R2R Supervisor Benelux France at Bristol-Myers Squibb, based in Chester, United Kingdom, with over two decades of experience in the pharmaceuticals industry.
Title and Current Role
Virginie Shandley is currently serving as the R2R Supervisor for the Benelux and France regions at Bristol-Myers Squibb. She operates from Chester, United Kingdom, overseeing Record to Report and General Accounting processes for several entities.
Previous Roles at Bristol-Myers Squibb
Virginie Shandley has held various positions at Bristol-Myers Squibb, showcasing her extensive experience in the pharmaceutical industry. Her roles have included P2P Lead at the European Capability Centre (2014-2016), Global Process Owner Expenditures (2013-2014), and Middle-East Accountant (2011-2013). She has also worked as a Software Assets Manager for the EMEA region (2009-2011), a Senior General Accountant for France and Scandinavia markets (2008-2009), and a General Accountant for UK and Ireland markets (2005-2008).
Early Career at Bristol-Myers Squibb
Virginie Shandley began her long-standing career with Bristol-Myers Squibb in 1998 as an Accounts Payable Associate for France and the UK. She then served as a Payment Associate for the EMEA region from 2001 to 2004, followed by a role as a General Accountant for the UK and Ireland markets from 2005 to 2008.
Educational Background
Virginie Shandley holds a Master's Degree in Business/Managerial Economics from the University Pierre Mendes France Grenoble, completed between 1995 and 1997. She also earned a University Diploma of Technology in Accounting and Finance from the University Institute of Technology, Grenoble, from 1993 to 1995.
Skills and Expertise
Virginie Shandley has extensive experience in several key areas, including SAP Implementation, Account Reconciliation, KPI Dashboards, Internal Controls, and Process Implementation. Her strong background in accounting and finance is further supported by her over two decades of experience in the pharmaceutical industry.